Galmed reports results from the Open-Label part of the ARMOR study showing improvements in histology, imaging, and biomarkers with Aramchol Histological improvement in fibrosis (≥1 stage) was demonstrated in 39% of subjects according...

Imagene: The research done by Imagene and Sheba Medical Center was recently published in 'Modern Pathology' journal. TEL AVIV, Israel, September 13, 2022 (Newswire.com) - Imagene, an emerging leader in the field of AI-based precision...

In a tongue twister of a collaboration, partners Paige and Perspectum plan to pool pathology tools to progress prospective studies. Both companies are developing artificial intelligence-powered software that analyzes standard tissue...

SpIntellx: Seasoned precision healthcare executive brings deep leadership, commercial and operational experience PITTSBURGH (PRWEB) MAY 16, 2022 -- B. Dusty Majumdar, Ph.D. has been appointed as the Chief Executive Officer (CEO) of SpIntellx,...

Munich, Germany – Nov 7 2016 – Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful diagnostics, announced a program collaboration with Takeda Pharmaceuticals to enable comprehensive...

Enhancing the patient experience through a patient-centered approach to care is a growing priority for healthcare organizations. The primary objective of patient-centered care is to ensure a continuing relationship between the patient and his...